More variants of TLR7 gene found in young, healthy men with severe COVID-19

gene
Credit: Pixabay/CC0 Public Domain

Spanish-Dutch research has revealed two new mutations in the TLR7 gene in healthy young men who became seriously ill with severe Covid-19. It's becoming increasingly plausible that such mutations undermine a sufficient immune response against SARS-CoV-2, the researchers write in Frontiers in Immunology.

An infection with SARS-CoV-2 can lead to serious inflammation and even death in some individuals. Older age, male gender and chronic diseases such as diabetes and obesity increase the risk for a severe outcome. But these risk factors cannot explain why (very) severe Covid-19 also occurs in young, healthy men without a medical history.

Important factor in the immune system

Last year researchers from Radboudumc published an article in JAMA describing for the first time that in the TLR7 gene were a possible rare genetic risk factor. Two unrelated pairs of brothers became seriously ill with Covid-19 and one of them died, they reported. They all had a mutation in the TLR7 gene, which encodes the receptor that plays a role in the recognition of the coronavirus and initiates the antiviral immune response through induction of interferons. TLR7 thus appears to be an important factor in the defense against SARS-CoV-2.

Support

After this first publication, the findings were repeated in several studies. An Italian study of men over 60 years of age with severe COVID-19 found that more than 2 percent of severely affected men carried a genetic mutation in TLR7, leading to an impaired functioning TLR7 receptor. These variants were not found in any individual in the control group. The researchers again observed a hampered activation of interferon signaling, signifying that an optimal immune response could not be mounted. "A recently published study in the American Journal of Human Genetics, which looked for rare genetic through an association study in more than half a million people, also revealed TLR7 as the most important factor for severe Covid-19," says geneticist Alexander Hoischen from Radboudumc Nijmegen, the Netherlands.

Two new variants

With Caspar van der Made, Frank van de Veerdonk and other Radboudumc researchers who were involved as well in the first publication on TLR7, Hoischen has now published another study on TLR7 together with Spanish researchers. This time they screened 14 cases of severe Covid-19 in young, healthy men under the age of fifty, of whom 10 from Spain and 4 from the Netherlands. Hoischen says that "hitherto unknown mutations of the TLR7 gene were found in both a Spanish and a Dutch patient. In the Dutch patient again we saw the defective activation of the signaling and impaired production of interferon."

Preventive vaccination and more active screening

What made the Dutch case special is two of the patient's cousins had the same mutation. Although they were not yet eligible for vaccination at that time due to their young age, they were given priority based on the research. Van der Made says that "as far as we know, these family members had not yet been exposed to the coronavirus. We therefore decided to vaccinate them preventively, in order to greatly reduce the risk of serious illness from Covid-19. In our small-scale study, we provide an impetus for screening a selected group of young men, precisely because a diagnosis of TLR7 deficiency due to mutations in this gene can have consequences for treatment, such as the mentioned preventive vaccination." Hoischen: "Mutations in the TLR7 gene are now also listed as immune deficiency in OMIM – the international website where such information is registered."


Explore further

Genetic mutations predispose individuals to severe COVID-19

More information: Xavier Solanich et al, Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19, Frontiers in Immunology (2021). DOI: 10.3389/fimmu.2021.719115
Provided by Radboud University
Citation: More variants of TLR7 gene found in young, healthy men with severe COVID-19 (2021, August 3) retrieved 20 September 2021 from https://medicalxpress.com/news/2021-08-variants-tlr7-gene-young-healthy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
526 shares

Feedback to editors